Stephen Kessler, MD
Dermatology · Mesa, AZNPI 1336671312
Payments from drug & device makers
Across 98 payments — averaging $21.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$296
- LEO Pharma Inc.$264
- Sun Pharmaceutical Industries Inc.$207
- Regeneron Healthcare Solutions, Inc.$182
- Sanofi$155
- E.r. Squibb & Sons, L.L.C.$137
- plus $883 from 17 others
What the payments were for
- Food & beverage$2,125100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $296 |
| LEO Pharma Inc. | 13 | $264 |
| Sun Pharmaceutical Industries Inc. | 10 | $207 |
| Regeneron Healthcare Solutions, Inc. | 7 | $182 |
| Sanofi | 6 | $155 |
| E.r. Squibb & Sons, L.L.C. | 7 | $137 |
| Johnson & Johnson | 7 | $129 |
| Dermavant Sciences, Inc. | 6 | $106 |
| Novartis | 3 | $103 |
| Galderma Laboratories, L.p. | 4 | $94 |
| Arcutis Biotherapeutics, Inc. | 4 | $78 |
| Mimedx Group, Inc. | 3 | $67 |
| Biowound Solutions, Inc. | 3 | $54 |
| Kyowa Kirin, Inc. | 2 | $50 |
| Organogenesis Inc. | 2 | $45 |
| UCB, Inc. | 1 | $25 |
| Mayne Pharma Commercial LLC | 1 | $22 |
| Biofrontera Inc. | 1 | $20 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $20 |
| Incyte Corporation | 1 | $20 |
| Surgenex LLC | 1 | $19 |
| Integra Lifesciences Corporation | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
How this compares
$2,125 in reported general payments places this provider in the 45th percentile of 305 dermatology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 172 | $6,938 |
| Fluorouracil | 88 | $5,206 |
| Triamcinolone Acetonide | 313 | $4,201 |
| Doxycycline Hyclate | 103 | $3,970 |
| Ketoconazole | 135 | $2,131 |
| Clindamycin Phosphate | 95 | $1,944 |
| Tacrolimus | 12 | $1,277 |
| ValacyclovirValacyclovir Hcl | 21 | $831 |
| Metronidazole | 15 | $589 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 11 | $501 |
| Mupirocin | 19 | $133 |
| SsdSilver Sulfadiazine | 17 | $97 |
| Silver Sulfadiazine | 16 | $63 |
| Prednisone | 33 | $52 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Mesa
- Ronald GlickMesa$91K
- Zainab RashidMesa$14K
- Kenneth SteilPhoenix$15.6M
- Lindsay AckermanPhoenix$7.4M
- Sadra JazayeriPhoenix$5.2M
- Aaron MangoldScottsdale$4.9M
- James PehoushekGlendale$4.8M
- Carsten HamannPhoenix$1.7M
- Dathan HamannPhoenix$1.6M
- Anthony NuaraScottsdale$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.